Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing NaN - NaN of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Orange City, Florida
  • +27 more
Jul 19, 2023

Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

Recruiting
  • Metastatic Breast Cancer
  • Enobosarm & Abemaciclib Combo
  • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
  • Chandler, Arizona
  • +29 more
Feb 1, 2023

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma Trial in Houston (L-NMMA)

Recruiting
  • HER2-negative Breast Cancer
  • +3 more
  • Houston, Texas
    Houston Methodist Neal Cancer Center
Jan 12, 2023

Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)

Active, not recruiting
  • Metastatic Breast Cancer
  • Patritumab Deruxtecan
  • Newnan, Georgia
  • +25 more
Dec 5, 2022

Metastatic Breast Cancer Trial in Worldwide ((vic-)trastuzumab duocarmazine, Physician's choice)

Active, not recruiting
  • Metastatic Breast Cancer
  • (vic-)trastuzumab duocarmazine
  • Physician's choice
  • Mobile, Alabama
  • +89 more
Oct 20, 2022

Palbociclib in Real World Practice

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • non-interventional
  • Alabaster, Alabama
  • +304 more
Oct 10, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma Trial in United States (PV-10 (10% rose bengal

Recruiting
  • Cancer Metastatic to the Liver
  • +9 more
  • PV-10 (10% rose bengal disodium)
  • San Diego, California
  • +4 more
Mar 22, 2022

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Miami, Florida
  • +21 more
Mar 18, 2022

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Metastatic Breast Cancer Trial in United States (EZN-2208)

Terminated
  • Metastatic Breast Cancer
  • Sedona, Arizona
  • +35 more
Jan 29, 2022

Metastatic Breast Cancer Trial in United States (Irinotecan + Carboplatin, irinotecan + Carboplatin + erbitux)

Active, not recruiting
Has Results
  • Metastatic Breast Cancer
  • Irinotecan + Carboplatin
  • irinotecan + Carboplatin + erbitux
  • Birmingham, Alabama
  • +58 more
Dec 3, 2021

Metastatic Breast Cancer Trial in United States (Pertuzumab, Trastuzumab)

Completed
Has Results
  • Metastatic Breast Cancer
  • Tucson, Arizona
  • +15 more
Dec 3, 2021

Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)

Completed
Has Results
  • Metastatic Breast Cancer
  • Placebo
  • +4 more
  • Birmingham, Alabama
  • +119 more
Sep 27, 2021

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Metastatic Breast Cancer Trial in Puerto Rico, United States (Abemaciclib, Fulvestrant, Standard Chemotherapy)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Avondale, Arizona
  • +60 more
Jul 29, 2021

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Metastatic Breast Cancer Trial in Worldwide (paclitaxel, Reparixin, )

Completed
Has Results
  • Metastatic Breast Cancer
  • Mobile, Alabama
  • +76 more
May 7, 2021

Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))

Completed
Has Results
  • Locally Recurrent Breast Cancer
  • Metastatic Breast Cancer
  • NKTR-102
  • Treatment of Physician's Choice (TPC)
  • Flagstaff, Arizona
  • +152 more
May 6, 2021